"DOI","paper_doi","paper_title_x","count_atlas_x","Publication_PMID","Publication_link","count_lnpdb_x","lnp_id","ionizable_lipid","peg_lipid","sterol_lipid","helper_lipid","lipid_molar_ratio","particle_size_nm_std","pdi_std","zeta_potential_mv_std","encapsulation_efficiency_percent_std","loading_capacity_std","target_type","nucleic_acid_sequence","peg_lipid_original","ionizable_lipid_original","helper_lipid_original","sterol_lipid_original","ionizable_lipid_smiles","peg_lipid_smiles","sterol_lipid_smiles","helper_lipid_smiles","synthesis_info","bioactivity_profile","paper_title_y","paper_authors","paper_journal","paper_year","atlas_row_id","IL_name","HL_name","CHL_name","PEG_name","atlas_ratio","ratio_order","count_atlas_y","count_lnpdb_y","lnpdb_row_ids","IL_ratio","HL_ratio","CHL_ratio","PEG_ratio","matched_id"
"10.1038/s41587-019-0247-3","https://doi.org/10.1038/s41587-019-0247-3","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation",44,31570898,"https://www.nature.com/articles/s41587-019-0247-3",1128,981,"A2-Iso5-2DC18","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","102.5","0.2",,"60.3","WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","C14-PEG2000","A2Iso52DC18","DOPE","cholesterol","CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 5.3E+07 RLU (in vivo i.m.), 6.3E+06 RLU (HeLa), 1.1E+06 RLU (B16F10)","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']","Nature Biotechnology",2019,"Row32","A2Iso52DC18","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",3,3,"['Row1' 'Row1081' 'Row1117']",35,16,46.5,2.5,"Row0"
"10.1038/s41587-019-0247-3","https://doi.org/10.1038/s41587-019-0247-3","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation",44,31570898,"https://www.nature.com/articles/s41587-019-0247-3",1128,983,"A2-Iso5-2DC18","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","102.5","0.2",,"60.3","WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","C14-PEG2000","A2Iso52DC18","DOPE","cholesterol","CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 5.5E+07 RLU (in vivo i.m.)","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']","Nature Biotechnology",2019,"Row34","A2Iso52DC18","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",3,3,"['Row1' 'Row1081' 'Row1117']",35,16,46.5,2.5,"Row0"
"10.1038/s41587-019-0247-3","https://doi.org/10.1038/s41587-019-0247-3","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation",44,31570898,"https://www.nature.com/articles/s41587-019-0247-3",1128,984,"A2-Iso5-2DC18","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","110.6","0.1",,"50.4","WR:15(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","C14-PEG2000","A2Iso52DC18","DOPE","cholesterol","CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.15E+07 RLU (in vivo i.m.)","Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']","Nature Biotechnology",2019,"Row35","A2Iso52DC18","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",3,3,"['Row1' 'Row1081' 'Row1117']",35,16,46.5,2.5,"Row0"
